# clm_C49E0455CA9B

subject: Amgen (/record/amgen.md)  
predicate: revenue  
value: 28,190,000,000 United States dollar  
valid_from: 2023-12-31  
valid_to: 2024-12-31  
published: 2024-02-14  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_F31DA2CA4F3F  
last_updated: 2026-11-08  
cite: AsOf. "Amgen revenue: 28,190,000,000 United States dollar", as of 2023-12-31 (until 2024-12-31). Claim clm_C49E0455CA9B, https://asof.is/claim/clm_C49E0455CA9B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/0000318154-24-000011-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2023, filed 2024-02-14  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/0000318154-24-000011-index.htm (primary, SEC EDGAR 10-K FY2023, published 2024-02-14)

## Supersedes

- [Amgen](/record/amgen.md) | revenue | 26,323,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_C49E0455CA9B](/claim/clm_C49E0455CA9B.md) | [clm_142A6C7A0E55](/claim/clm_142A6C7A0E55.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.